Table 1 Correlations of major clinical/pathological factors and recurrence after CCRT and adjacent surgery in stage IIB–III cervical cancer
Factors | Number (%) | Recurrence | χ2 | p | ||
|---|---|---|---|---|---|---|
No | Yes | |||||
Age | <50 | 28(57.1) | 50 | 3 | 5. 168 | 0.023* |
≥50 | 21(42.9) | 13 | 8 | |||
HPV infection | No | 31(63.3) | 25 | 6 | 0.464 | 0.496 |
Yes | 18(36.7) | 13 | 5 | |||
Tumor diameters | ≤4 cm | 20(40.8) | 14 | 6 | 1.107 | 0.293 |
>4 cm | 29(59.2) | 24 | 5 | |||
Pathological differentiation | High | 7(14.3) | 5 | 2 | 0.979 | 0.613 |
Moderatly | 33(67.3) | 25 | 8 | |||
Low | 9(18.4) | 8 | 1 | |||
Pathologic subtypes | Adenocarcinoma/mixed subtypes | 7(14.3) | 4 | 3 | 1.954 | 0.162 |
SCC | 42(85.7) | 34 | 8 | |||
FIGO stage | IIB | 41(83.7) | 32 | 9 | 0.657 | 0.720 |
IIIA | 1(2.0) | 1 | 0 | |||
IIIB | 7(14.3) | 5 | 2 | |||
Microscopic residual | No | 27(55.1) | 20 | 7 | 8.920 | 0.012* |
Disease invading less than 50% of the myometrium | 13(26.5) | 13 | 0 | 8.920 | 0.012* | |
Disease invading more than 50% of the myometrium | 9(18.4) | 5 | 4 | |||